|Articles|December 14, 2018
Top Health-System Trends Highlight SPT Week in Review
Author(s)SPT Staff
Top news of the week from Specialty Pharmacy Times.
Advertisement
5. Age-Related Macular Degeneration Drug Combo Scrapped Despite Safe Profile
Zimura (avacincaptad pegol) was generally well tolerated when given to patients in combination with ranibizumab (Lucentis), but Ophthotech Corp announced it will focus efforts on other clinical programs.
4. Accelerated Biological Aging from Breast Cancer Treatment May Lead to Cognitive Dysfunction
Study examines whether markers of biological aging due to cancer treatment are related to cognitive function in survivors of breast cancer.
3. Should Cognitive Function Decline Prompt Changing Multiple Sclerosis Treatments?
Experts argue whether a decline in cognitive function should lead to a change in disease-modifying therapy for multiple sclerosis.
2. Routine Versus Targeted Hepatitis C Testing in US State Prisons
Study shows that routinely screening inmates for hepatitis C virus at entry may identify a significant number of cases that would have been missed through targeted testing.
1. Specialty Spending Among Top 5 Health-System Pharmacy Trends to Watch
The specialty drug market saw a 16% growth rate in 2018.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
Experimental Vaccine Shows 73% Efficacy Against Salmonella Paratyphi A
3
COVID-19 Reinfection Heightens Risk of Postacute Sequelae of SARS-CoV-2 in Pediatrics
4
Pharmacists Key to Counseling and Monitoring Patients Transitioning to Low-Sodium Oxybate
5
